Author(s): C. Muralikrishna Goud

Email(s): muralikrishna1789@gmail.com

DOI: 10.5958/2231-5659.2020.00048.X   

Address: C. Muralikrishna Goud
Shadan College of Pharmacy, Peerancheru, Himayatsagar road, Hyderabad, Telangana, India, 500091.
*Corresponding Author

Published In:   Volume - 10,      Issue - 4,     Year - 2020


ABSTRACT:
The aim of present review is to provide an insight on FDA updates in it's own words on coronavirus disease 2019. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Cite this article:
C. Muralikrishna Goud. Coronavirus Disease 2019 - FDA Updates. Asian J. Res. Pharm. Sci. 2020; 10(4):273-281. doi: 10.5958/2231-5659.2020.00048.X


REFERENCES:
1.    WHO - timeline - covid-19 https://www.who.int/news-room/detail/ 27-04-2020-who-timeline---covid
2.    Information on COVID 19, the infectious disease caused by the most recently discovered Coronavirus. www.who.int https:// www.who.int/emergencies/diseases/novel-coronavirus-2019
3.    Coronavirus www.who.int https://www.who.int/health-topics/ coronavirus#tab=tab_1
4.    Coronavirus (COVID-19) Update: Daily Roundup. www.fda.gov/ news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-8-2020.
5.    Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens. https://www.fda.gov/news-events/press-announcements/ coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-using-home-collection-saliva
6.    Coronavirus (COVID-19) Update: FDA Continues to Combat Fraudulent COVID-19 Medical Products. https://www.fda.gov/ news-events/press-announcements/ coronavirus-covid-19-update-fda-continues-combat-fraudulent-covid-19-medical-products
7.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-6-2020
8.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-5-2020
9.    Coronavirus (COVID-19) Update: Daily Roundup https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-4-2020
10.    Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy. https://www.fda.gov/news-events/fda-voices/insight-fdas-revised-policy-antibody-tests-prioritizing-access-and-accura
11.    Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment
12.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-30-2020
13.    Helpful Questions and Answers about Coronavirus (COVID-19) and Your Pets. https://www.fda.gov/consumers/consumer-updates/helpful-questions-and-answers-about-coronavirus-covid-19-and-your-pets
14.    Webinar: Conducting Clinical Trials During the COVID-19 Public Health Emergency. https://www.fda.gov/drugs/news-events-human-drugs/sbia-webinar-conducting-clinical-trials-during-covid-19-public-health-emergency-04302020-04302020
15.    Tips on Good Nutrition and Using the Updated Nutrition Facts Label During the Coronavirus Pandemic. https://www.fda.gov/ consumers/consumer-updates/tips-good-nutrition-and-using-updated-nutrition-facts-label-during-coronavirus-pandemic
16.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-28-2020
17.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-27-2020
18.    Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems. https://www.fda.gov/news-events/press-announcements/ coronavirus-covid-19-update-fda-reiterates-importance-close-patient-supervision-label-use
19.    Virtual Town Hall Series - Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests. https://www.fda.gov/ medical-devices/workshops-conferences-medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-05132020
20.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-22-2020
21.    FDA Provides Flexibility to the Food Industry to Support Food Supply Chain and Meet Consumer Demand During COVID-19. https://www.fda.gov/news-events/fda-voices/fda-provides-flexibility-food-industry-support-food-supply-chain-and-meet-consumer-demand-during
22.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-21-2020
23.    The Path Forward: Coronavirus Treatment Acceleration Program https://www.fda.gov/news-events/fda-voices/path-forward-coronavirus-treatment-acceleration-program
24.    Coronavirus (COVID-19) Update: Serological Test Validation and Education Efforts. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-serological-test-validation-and-education-efforts
25.    Coronavirus (COVID-19) Update: Daily Roundup. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-april-17-2020
26.    FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies. https://www.fda.gov/ news-events/press-announcements/coronavirus-covid-19-update-fda-encourages-recovered-patients-donate-plasma-development-blood
27.    Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Decontaminate Millions of N95 Respirators https://www.fda.gov/news-events/press-announcements/ coronavirus-covid-19-update-fda-issues-emergency-use-authorization-decontaminate-millions-n95
28.    Coronavirus (COVID-19) Update:FDA Authorizes Blood Purification Device to Treat COVID-19 https://www.fda.gov/ news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-treat-covid-19
29.    Coronavirus (COVID-19) Update: FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19 https://www.fda.gov/news-events/press-announcements/ coronavirus-covid-19-update-fda-coordinates-national-effort-develop-blood-related-therapies-covid-19
30.    Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic. https://www.fda.gov/news-events/press-announcements /coronavirus-covid-19-update-fda-provides-updated-guidance-address-urgent-need-blood-during-pandemic
31.    Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-accelerate-development-novel-therapies-covid-19
32.    FDA on Signing of the COVID-19 Emergency Relief Bill, Including Landmark Over-the-Counter Drug Reform and User Fee Legislation. https://www.fda.gov/news-events/press-announcements/fda-signing-covid-19-emergency-relief-bill-including-landmark-over-counter-drug-reform-and-user-fee
33.    FDA, Department of Veterans Affairs, National Institutes of Health, and America Makes Form a COVID-19 Response Public-Private Partnership. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/fda-efforts-connect-manufacturers-and-health-care-entities-fda-department-veterans-affairs-national
34.    Coronavirus (COVID-19) Update: FDA Alerts Consumers About Unauthorized Fraudulent COVID-19 Test Kits. https:// www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-alerts-consumers-about-unauthorized-fraudulent-covid-19-test-kits
35.    Coronavirus (COVID-19) Update: FDA provides guidance on production of alcohol-based hand sanitizer to help boost supply, protect public health. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-provides-guidance-production-alcohol-based-hand-sanitizer-help-boost
36.    Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-update-fda-and-ftc-warn-seven-companies-selling-fraudulent-products-claim-treat-or
37.    Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to respirators, including N95s, for health care personnel. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-and-cdc-take-action-increase-access-respirators-including-n95s
38.    FDA Takes Significant Step in Coronavirus Response Efforts, Issues Emergency Use Authorization (EUA) for the First 2019 Novel Coronavirus Diagnostic. https://www.fda.gov/news-events/ press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first
39.    FDA Announces Key Actions to Advance Development of Novel Coronavirus Medical Countermeasures https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures

Recomonded Articles:

Author(s): Lakshmi Prasanna J., Deepthi B., Rama Rao N.

DOI:         Access: Open Access Read More

Author(s): Saudagar R. B., Sarika V. Khandbahale

DOI: 10.5958/2231-5659.2017.00005.4         Access: Open Access Read More

Author(s): Beatrice Y. Danladi, P. Geetha

DOI: 10.5958/2231-5659.2017.00031.5         Access: Open Access Read More

Author(s): Manukondakeerthi, Lakshmiprasanna. J, Santhosh aruna M, Rama Rao N

DOI:         Access: Open Access Read More

Author(s): AK Mohiuddin

DOI: 10.5958/2231-5659.2019.00004.3         Access: Closed Access Read More

Author(s): Yogita V. Dalvi

DOI: 10.5958/2231-5659.2018.00025.5         Access: Open Access Read More

Author(s): Mukesh Sharma, Kushagra Nagori, Shubhang Agrawal, Vinay S. Verma, Hemendra Swarnakar, Sanjay Vaishnav, Md. Nazir, Nasim Khan, Ajay Singh

DOI:         Access: Open Access Read More

Author(s): D.M. Shinkar, Bhushan S Bhamare, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00011.4         Access: Open Access Read More

Author(s): Seema Thakur, Neha Srivastava

DOI: 10.5958/2231-5659.2016.00012.6         Access: Open Access Read More

Author(s): S. S. Shuka, Bina Gidwani, R. Pandey, S. P. Rao, V. Singh, Amber Vyas

DOI:         Access: Open Access Read More

Author(s): Ameena Samreen, Mohammed Riyaz, Amtul Asiya, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5659.2017.00007.8         Access: Open Access Read More

Author(s): Vrushali R. Kadam, M. P. Patil, Vrushali V. Pawar, Sanjay Kshirsagar

DOI: 10.5958/2231-5659.2017.00030.3         Access: Open Access Read More

Author(s): Farheen Fatima Ahsan, Afreen Fatima, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5659.2017.00002.9         Access: Open Access Read More

Author(s): Nikunja B. Pati, T. Swayam Jyothi, Gajender Singh Thakur, Sushma Reddy, G. Meghna

DOI: 10.5958/2231-5659.2017.00028.5         Access: Open Access Read More

Author(s): Pratibha Gavarkar, Pramod Patil, Akshay Sutar, Shridhar Rasal, Dyaneshwar Surwase

DOI: 10.5958/2231-5659.2016.00029.1         Access: Open Access Read More

Author(s): Sana Banu, Syeda Ayesha Farheen

DOI: 10.5958/2231-5659.2019.00015.8         Access: Closed Access Read More

Author(s): Priya Rahade, Sandeep Sonawane, Atharva Bhalerao, Sanjay Kshirsagar

DOI:         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-5659 


Recent Articles




Tags